Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Efflux transport of nicotine, cotinine and trans-3'-hydroxycotinine glucuronides by human hepatic transporters.

Järvinen E, Sjöstedt N, Koenderink JB, Kidron H, Finel M.

Basic Clin Pharmacol Toxicol. 2019 Jun 24. doi: 10.1111/bcpt.13281. [Epub ahead of print]

PMID:
31237077
2.

Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis.

Verscheijden LFM, Koenderink JB, de Wildt SN, Russel FGM.

PLoS Comput Biol. 2019 Jun 13;15(6):e1007117. doi: 10.1371/journal.pcbi.1007117. eCollection 2019 Jun.

3.

Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT).

Zwartsen A, Litjens CHC, Hondebrink L, van den Heuvel JJMW, Greupink R, Russel FGM, de Lange DW, Legler J, Koenderink JB, Westerink RHS.

Toxicology. 2019 Jun 15;422:69-75. doi: 10.1016/j.tox.2019.04.012. Epub 2019 Apr 19.

4.

Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicity.

Weigand KM, Schirris TJJ, Houweling M, van den Heuvel JJMW, Koenderink JB, Dankers ACA, Russel FGM, Greupink R.

Toxicol In Vitro. 2019 Apr;56:52-61. doi: 10.1016/j.tiv.2019.01.003. Epub 2019 Jan 9.

5.

Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients.

Te Brake LHM, Yunivita V, Livia R, Soetedjo N, van Ewijk-Beneken Kolmer E, Koenderink JB, Burger DM, Santoso P, van Crevel R, Alisjahbana B, Aarnoutse RE, Ruslami R; on behalf of the TANDEM Consortium.

Clin Pharmacol Ther. 2019 Mar;105(3):730-737. doi: 10.1002/cpt.1232. Epub 2018 Oct 29.

6.

Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.

van der Velden M, Bilos A, van den Heuvel JJMW, Rijpma SR, Hurkmans EGE, Sauerwein RW, Russel FGM, Koenderink JB.

Malar J. 2017 Oct 23;16(1):422. doi: 10.1186/s12936-017-2062-y.

7.

The Role of Efflux Pumps in Tuberculosis Treatment and Their Promise as a Target in Drug Development: Unraveling the Black Box.

Te Brake LHM, de Knegt GJ, de Steenwinkel JE, van Dam TJP, Burger DM, Russel FGM, van Crevel R, Koenderink JB, Aarnoutse RE.

Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:271-291. doi: 10.1146/annurev-pharmtox-010617-052438. Epub 2017 Jul 17. Review.

PMID:
28715978
8.

Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.

Kavishe RA, Koenderink JB, Alifrangis M.

FEBS J. 2017 Aug;284(16):2579-2591. doi: 10.1111/febs.14097. Epub 2017 May 25. Review.

9.

Transmembrane Domain Single-Nucleotide Polymorphisms Impair Expression and Transport Activity of ABC Transporter ABCG2.

Sjöstedt N, van den Heuvel JJMW, Koenderink JB, Kidron H.

Pharm Res. 2017 Aug;34(8):1626-1636. doi: 10.1007/s11095-017-2127-1. Epub 2017 Mar 9.

10.

Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways.

Tesselaar MH, Crezee T, Swarts HG, Gerrits D, Boerman OC, Koenderink JB, Stunnenberg HG, Netea MG, Smit JW, Netea-Maier RT, Plantinga TS.

Mol Cancer Ther. 2017 Jan;16(1):169-181. doi: 10.1158/1535-7163.MCT-16-0460. Epub 2016 Nov 11.

11.

Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol.

Te Brake LH, van den Heuvel JJ, Buaben AO, van Crevel R, Bilos A, Russel FG, Aarnoutse RE, Koenderink JB.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7105-7114. Print 2016 Dec.

12.

Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.

van der Velden M, Rijpma SR, Verweij V, van Gemert GJ, Chevalley-Maurel S, van de Vegte-Bolmer M, Franke-Fayard BM, Russel FG, Janse CJ, Sauerwein RW, Koenderink JB.

Am J Trop Med Hyg. 2016 Aug 3;95(2):378-82. doi: 10.4269/ajtmh.16-0226. Epub 2016 Jun 13.

13.

Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.

Lempers VJ, van den Heuvel JJ, Russel FG, Aarnoutse RE, Burger DM, Brüggemann RJ, Koenderink JB.

Antimicrob Agents Chemother. 2016 May 23;60(6):3372-9. doi: 10.1128/AAC.02931-15. Print 2016 Jun.

14.

Vital and dispensable roles of Plasmodium multidrug resistance transporters during blood- and mosquito-stage development.

Rijpma SR, van der Velden M, Annoura T, Matz JM, Kenthirapalan S, Kooij TW, Matuschewski K, van Gemert GJ, van de Vegte-Bolmer M, Siebelink-Stoter R, Graumans W, Ramesar J, Klop O, Russel FG, Sauerwein RW, Janse CJ, Franke-Fayard BM, Koenderink JB.

Mol Microbiol. 2016 Jul;101(1):78-91. doi: 10.1111/mmi.13373. Epub 2016 May 23.

15.

MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparum.

Rijpma SR, van der Velden M, Bilos A, Jansen RS, Mahakena S, Russel FG, Sauerwein RW, van de Wetering K, Koenderink JB.

FEBS Lett. 2016 Feb;590(4):482-92. doi: 10.1002/1873-3468.12079. Epub 2016 Feb 17.

16.

Heterogeneous transport of digitalis-like compounds by P-glycoprotein in vesicular and cellular assays.

Gozalpour E, Wilmer MJ, Bilos A, Masereeuw R, Russel FG, Koenderink JB.

Toxicol In Vitro. 2016 Apr;32:138-45. doi: 10.1016/j.tiv.2015.12.009. Epub 2015 Dec 17.

PMID:
26708294
17.

ATPase Activity Measurements Using Radiolabeled ATP.

Swarts HG, Koenderink JB.

Methods Mol Biol. 2016;1377:121-6. doi: 10.1007/978-1-4939-3179-8_13.

PMID:
26695028
18.

Expression of Na,K-ATPase and H,K-ATPase Isoforms with the Baculovirus Expression System.

Koenderink JB, Swarts HG.

Methods Mol Biol. 2016;1377:71-8. doi: 10.1007/978-1-4939-3179-8_8.

PMID:
26695023
19.

Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.

Te Brake LH, Russel FG, van den Heuvel JJ, de Knegt GJ, de Steenwinkel JE, Burger DM, Aarnoutse RE, Koenderink JB.

Tuberculosis (Edinb). 2016 Jan;96:150-7. doi: 10.1016/j.tube.2015.08.004. Epub 2015 Oct 9.

PMID:
26682943
20.

Feline hepatic biotransformation of diazepam: Differences between cats and dogs.

van Beusekom CD, van den Heuvel JJ, Koenderink JB, Russel FG, Schrickx JA.

Res Vet Sci. 2015 Dec;103:119-25. doi: 10.1016/j.rvsc.2015.09.016. Epub 2015 Sep 25.

PMID:
26679806
21.

Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites.

Rijpma SR, van der Velden M, González-Pons M, Annoura T, van Schaijk BC, van Gemert GJ, van den Heuvel JJ, Ramesar J, Chevalley-Maurel S, Ploemen IH, Khan SM, Franetich JF, Mazier D, de Wilt JH, Serrano AE, Russel FG, Janse CJ, Sauerwein RW, Koenderink JB, Franke-Fayard BM.

Cell Microbiol. 2016 Mar;18(3):369-83. doi: 10.1111/cmi.12517. Epub 2015 Nov 10.

22.

PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs.

van der Velden M, Rijpma SR, Russel FG, Sauerwein RW, Koenderink JB.

Malar J. 2015 Feb 14;14:76. doi: 10.1186/s12936-015-0581-y.

23.

Exposure to total and protein-unbound rifampin is not affected by malnutrition in Indonesian tuberculosis patients.

te Brake LH, Ruslami R, Later-Nijland H, Mooren F, Teulen M, Apriani L, Koenderink JB, Russel FG, Burger DM, Alisjahbana B, Wieringa F, van Crevel R, Aarnoutse RE.

Antimicrob Agents Chemother. 2015;59(6):3233-9. doi: 10.1128/AAC.03485-14. Epub 2015 Mar 23.

24.

Na(+),K(+)-ATPase isoform selectivity for digitalis-like compounds is determined by two amino acids in the first extracellular loop.

Weigand KM, Laursen M, Swarts HG, Engwerda AH, Prüfert C, Sandrock J, Nissen P, Fedosova NU, Russel FG, Koenderink JB.

Chem Res Toxicol. 2014 Dec 15;27(12):2082-92. doi: 10.1021/tx500290k. Epub 2014 Nov 12.

PMID:
25361285
25.

Convallatoxin: a new P-glycoprotein substrate.

Gozalpour E, Greupink R, Bilos A, Verweij V, van den Heuvel JJ, Masereeuw R, Russel FG, Koenderink JB.

Eur J Pharmacol. 2014 Dec 5;744:18-27. doi: 10.1016/j.ejphar.2014.09.031. Epub 2014 Sep 28.

PMID:
25264938
26.

Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity.

Rijpma SR, van den Heuvel JJ, van der Velden M, Sauerwein RW, Russel FG, Koenderink JB.

Malar J. 2014 Sep 13;13:359. doi: 10.1186/1475-2875-13-359.

27.

A missense variant of the ATP1A2 gene is associated with a novel phenotype of progressive sensorineural hearing loss associated with migraine.

Oh SK, Baek JI, Weigand KM, Venselaar H, Swarts HG, Park SH, Hashim Raza M, Jung DJ, Choi SY, Lee SH, Friedrich T, Vriend G, Koenderink JB, Kim UK, Lee KY.

Eur J Hum Genet. 2015 May;23(5):639-45. doi: 10.1038/ejhg.2014.154. Epub 2014 Aug 20.

28.

Detergent-free purification of ABC (ATP-binding-cassette) transporters.

Gulati S, Jamshad M, Knowles TJ, Morrison KA, Downing R, Cant N, Collins R, Koenderink JB, Ford RC, Overduin M, Kerr ID, Dafforn TR, Rothnie AJ.

Biochem J. 2014 Jul 15;461(2):269-78. doi: 10.1042/BJ20131477.

PMID:
24758594
29.

Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.

Gozalpour E, Greupink R, Wortelboer HM, Bilos A, Schreurs M, Russel FG, Koenderink JB.

Mol Pharm. 2014 Jun 2;11(6):1844-55. doi: 10.1021/mp400699p. Epub 2014 May 6.

PMID:
24754247
30.

In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors.

Ritschel T, Hermans SM, Schreurs M, van den Heuvel JJ, Koenderink JB, Greupink R, Russel FG.

Chem Res Toxicol. 2014 May 19;27(5):873-81. doi: 10.1021/tx5000393. Epub 2014 Apr 23.

PMID:
24713091
31.

Biochemical characterization of sporadic/familial hemiplegic migraine mutations.

Weigand KM, Swarts HG, Russel FG, Koenderink JB.

Biochim Biophys Acta. 2014 Jul;1838(7):1693-700. doi: 10.1016/j.bbamem.2014.03.022. Epub 2014 Apr 3.

32.

Alternating Hemiplegia of Childhood mutations have a differential effect on Na(+),K(+)-ATPase activity and ouabain binding.

Weigand KM, Messchaert M, Swarts HG, Russel FG, Koenderink JB.

Biochim Biophys Acta. 2014 Jul;1842(7):1010-6. doi: 10.1016/j.bbadis.2014.03.002. Epub 2014 Mar 12.

33.

Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus.

El-Sheikh AA, Koenderink JB, Wouterse AC, van den Broek PH, Verweij VG, Masereeuw R, Russel FG.

Transl Res. 2014 Jul;164(1):46-56. doi: 10.1016/j.trsl.2014.01.006. Epub 2014 Jan 10.

PMID:
24486136
34.

The feline bile salt export pump: a structural and functional comparison with canine and human Bsep/BSEP.

van Beusekom CD, van den Heuvel JJ, Koenderink JB, Schrickx JA, Russel FG.

BMC Vet Res. 2013 Dec 20;9:259. doi: 10.1186/1746-6148-9-259.

35.

Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.

Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha JF, Mosha DF, van Zwetselaar M, Koenderink JB, Mosha FW, Alifrangis M, Reyburn H, Roper C, Kavishe RA.

Malar J. 2013 Nov 14;12:415. doi: 10.1186/1475-2875-12-415.

36.

Amino acid substitutions of Na,K-ATPase conferring decreased sensitivity to cardenolides in insects compared to mammals.

Dalla S, Swarts HG, Koenderink JB, Dobler S.

Insect Biochem Mol Biol. 2013 Dec;43(12):1109-15. doi: 10.1016/j.ibmb.2013.09.006. Epub 2013 Oct 8.

PMID:
24121093
37.

Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.

El-Sheikh AA, Greupink R, Wortelboer HM, van den Heuvel JJ, Schreurs M, Koenderink JB, Masereeuw R, Russel FG.

Transl Res. 2013 Dec;162(6):398-409. doi: 10.1016/j.trsl.2013.08.003. Epub 2013 Sep 12.

PMID:
24036158
38.

Familial hemiplegic migraine mutations affect Na,K-ATPase domain interactions.

Swarts HG, Weigand KM, Venselaar H, van den Maagdenberg AM, Russel FG, Koenderink JB.

Biochim Biophys Acta. 2013 Dec;1832(12):2173-9. doi: 10.1016/j.bbadis.2013.08.003. Epub 2013 Aug 15.

39.

Interaction of digitalis-like compounds with p-glycoprotein.

Gozalpour E, Wittgen HG, van den Heuvel JJ, Greupink R, Russel FG, Koenderink JB.

Toxicol Sci. 2013 Feb;131(2):502-11. doi: 10.1093/toxsci/kfs307. Epub 2012 Oct 26.

PMID:
23104431
40.

Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity.

Wagener FA, Dankers AC, van Summeren F, Scharstuhl A, van den Heuvel JJ, Koenderink JB, Pennings SW, Russel FG, Masereeuw R.

Curr Pharm Des. 2013;19(15):2698-707.

PMID:
23092328
41.

Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones.

Dankers AC, Sweep FC, Pertijs JC, Verweij V, van den Heuvel JJ, Koenderink JB, Russel FG, Masereeuw R.

Cell Tissue Res. 2012 Aug;349(2):551-63. doi: 10.1007/s00441-012-1417-5. Epub 2012 May 13.

42.

Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity.

Wittgen HG, van den Heuvel JJ, Krieger E, Schaftenaar G, Russel FG, Koenderink JB.

Biochem Pharmacol. 2012 Aug 1;84(3):366-73. doi: 10.1016/j.bcp.2012.04.012. Epub 2012 Apr 21.

PMID:
22542979
43.

Exploiting transport activity of p-glycoprotein at the blood-brain barrier for the development of peripheral cannabinoid type 1 receptor antagonists.

Wittgen HG, Greupink R, van den Heuvel JJ, van den Broek PH, Dinter-Heidorn H, Koenderink JB, Russel FG.

Mol Pharm. 2012 May 7;9(5):1351-60. doi: 10.1021/mp200617z. Epub 2012 Mar 28.

PMID:
22428727
44.

Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.

Wittgen HG, van den Heuvel JJ, van den Broek PH, Siissalo S, Groothuis GM, de Graaf IA, Koenderink JB, Russel FG.

Drug Metab Dispos. 2012 Jun;40(6):1076-9. doi: 10.1124/dmd.111.044438. Epub 2012 Mar 12.

PMID:
22415933
45.

Na,K-ATPase activity modulates Src activation: a role for ATP/ADP ratio.

Weigand KM, Swarts HG, Fedosova NU, Russel FG, Koenderink JB.

Biochim Biophys Acta. 2012 May;1818(5):1269-73. doi: 10.1016/j.bbamem.2012.01.015. Epub 2012 Jan 24.

46.

Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4.

Wittgen HG, van den Heuvel JJ, van den Broek PH, Dinter-Heidorn H, Koenderink JB, Russel FG.

Drug Metab Dispos. 2011 Jul;39(7):1294-302. doi: 10.1124/dmd.110.037812. Epub 2011 Apr 21.

PMID:
21511945
47.

The ABCs of multidrug resistance in malaria.

Koenderink JB, Kavishe RA, Rijpma SR, Russel FG.

Trends Parasitol. 2010 Sep;26(9):440-6. doi: 10.1016/j.pt.2010.05.002. Epub 2010 Jun 11. Review.

PMID:
20541973
48.

In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.

Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S, Koenderink JB, Luty AJ, Whitty CJ, Drakeley C, Sauerwein RW, Bousema T.

Antimicrob Agents Chemother. 2010 May;54(5):1762-8. doi: 10.1128/AAC.01135-09. Epub 2010 Mar 1.

49.

Familial hemiplegic migraine is associated with febrile seizures in an FHM2 family with a novel de novo ATP1A2 mutation.

de Vries B, Stam AH, Kirkpatrick M, Vanmolkot KR, Koenderink JB, van den Heuvel JJ, Stunnenberg B, Goudie D, Shetty J, Jain V, van Vark J, Terwindt GM, Frants RR, Haan J, van den Maagdenberg AM, Ferrari MD.

Epilepsia. 2009 Nov;50(11):2503-4. doi: 10.1111/j.1528-1167.2009.02186.x. No abstract available.

50.

FXYD2 and Na,K-ATPase expression in isolated human proximal tubular cells: disturbed upregulation on renal hypomagnesemia?

Cairo ER, Swarts HG, Wilmer MJ, Willems PH, Levtchenko EN, De Pont JJ, Koenderink JB.

J Membr Biol. 2009 Oct;231(2-3):117-24. doi: 10.1007/s00232-009-9210-4. Epub 2009 Oct 29.

Supplemental Content

Loading ...
Support Center